Join us on Sunday prior to BIO-Europe Our annual Pre-BIO-Europe BYO primer will be held at O'Leary's on Sunday, November 3 at 5 pm (or, 1700, if you prefer).O'Leary's is located…
Biotech industry poised for boom: 2023 licensing & M&A predictions.
https://youtu.be/69azx95XaGQ Here is our annual year in review, along with some predictions (which are rarely correct) for 2023.
Is this 2020?Consider the following scenario…It is the beginning of the calendar year.A heretofore new and unknown virus is circulating the globe, causing significant morbidity and mortality.Half-way through the year,…
Happy New Year, everybody. And with the new year comes the annual report from the FDA/CDER on novel drug approvals. CDER approve8 48 novel candidates in 2019, down from the 59 approvals…
Which stories were the most interesting in 2019? And, what should we look forward to in 2020?In this video, we answer these questions. This is the third or fourth year…
What is Digital Scouting? The term “digital scouting” refers to an increasingly popular approach taken by multinational pharmaceutical companies to source and evaluate in-licensing opportunities.As the name implies, it…
Good stuff... BIO recently published their latest report characterizing innovation in highly prevalent, chronic diseases. A full list of past reports is available here. They are short, data-rich, and quite…
Congrats on beginning your quest towards the Holiest of Grails in our industry...capital. Your Board has given you a "simple" mandate: Find an investor or a licensing partner for the…
The August Edition of Life Science Leader has a summary of a panel discussion. The article is available here, and is well worth the time to read it if you…